Evaluation Studies as Topic. Critique . Evaluation Indexes . Evaluation Methodology . Evaluation Report . Evaluation Research . Methodology, Evaluation . Pre-Post Tests . Qualitative Evaluation . Quantitative Evaluation . Theoretical Effectiveness . Use-Effectiveness . Critiques . Effectiveness, Theoretical . Evaluation Methodologies . Evaluation Reports . Evaluation, Qualitative . Evaluation, Quantitative . Evaluations, Qualitative . Evaluations, Quantitative . Indexes, Evaluation . Methodologies, Evaluation . Pre Post Tests . Pre-Post Test . Qualitative Evaluations . Quantitative Evaluations . Report, Evaluation . Reports, Evaluation . Research, Evaluation . Test, Pre-Post . Tests, Pre-Post . Use Effectiveness . Evaluation Methods . Evaluation Techniques . Status Report . Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. . 1.00
Evaluation Studies. Evaluation Studies [Publication Type] . Works consisting of studies determining the effectiveness or utility of processes, personnel, and equipment. . 0.80
Clinical Trials, Phase II as Topic. Drug Evaluation, FDA Phase 2 as Topic . Drug Evaluation, FDA Phase II as Topic . Evaluation Studies, FDA Phase 2 as Topic . Evaluation Studies, FDA Phase II as Topic . Phase II Clinical Trials as Topic . Phase II Clinical Trials . Drug Evaluation, FDA Phase II . Evaluation Studies, FDA Phase II . Clinical Trials, Phase II . Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries. . 0.77
Clinical Trials, Phase III as Topic. Clinical Trials, Phase 3 as Topic . Drug Evaluation, FDA Phase 3 as Topic . Drug Evaluation, FDA Phase III as Topic . Evaluation Studies, FDA Phase 3 as Topic . Evaluation Studies, FDA Phase III as Topic . Phase III Clinical Trials as Topic . Drug Evaluation, FDA Phase III . Evaluation Studies, FDA Phase III . Phase III Clinical Trials . Clinical Trials, Phase III . Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries. . 0.76
Clinical Trials, Phase IV as Topic. Clinical Trials, Phase 4 as Topic . Drug Evaluation, FDA Phase 4 as Topic . Drug Evaluation, FDA Phase IV as Topic . Evaluation Studies, FDA Phase 4 as Topic . Evaluation Studies, FDA Phase IV as Topic . Drug Evaluation, FDA Phase IV as Topic . Evaluation Studies, FDA Phase IV as Topic . Phase IV Clinical Trials as Topic . Phase IV Clinical Trials . Drug Evaluation, FDA Phase IV . Evaluation Studies, FDA Phase IV . Clinical Trials, Phase IV . Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries. . 0.76
Drug Evaluation. Drug Evaluation Studies . Drug Evaluation Study . Drug Evaluations . Evaluation Study, Drug . Evaluation, Drug . Evaluations, Drug . Studies, Drug Evaluation . Study, Drug Evaluation . Evaluation Studies, Drug . Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. . 0.71
